The Heart of Life Science on the Web

Wide Blue 19 September 2025

Glasgow-based companies MR CoilTech and Wideblue are collaborating with the University of Glasgow on developing advanced MRI scanning technology which has the potential to enhance research into the understanding and treatment of Alzheimer’s disease.

Recently a new range of monoclonal anti-body drugs have been introduced which are intended to slow the progress of the disease by targeting clumps of the protein beta-amyloid which form plaques in the patient’s brain; plaques are a characteristic sign of Alzheimer’s disease. The new head coil MRI scanner technology may provide super-fine resolution images which can potentially identify these plaques and monitor effectiveness of treatment. The new technology could monitor the progress of patients taking these drugs, identify side effects and provide data on which patients could potentially benefit the most from these medications.

Read the full article at PharmiWeb: The Heart of Life Science on the Web